Trinity Biotech PLCNASDAQ:TRIBNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5500
- TODAY'S CHANGE (%)0.0400 (7.8431%)
- Bid / Lots0.4101/ 8
- Ask / Lots0.6213/ 5
- Open / Previous Close0.5500 / 0.5100
- Day Range
- 52 Week Range
- Volume38,204
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TRIB |
|---|---|---|
| 09:32 ET | 300 | 0.55 |
| 09:51 ET | 100 | 0.5277 |
| 09:53 ET | 103 | 0.5139 |
| 10:06 ET | 125 | 0.5276 |
| 10:08 ET | 100 | 0.5277 |
| 10:36 ET | 100 | 0.55 |
| 11:43 ET | 100 | 0.55 |
| 12:15 ET | 5000 | 0.506 |
| 12:17 ET | 5000 | 0.50644 |
| 12:21 ET | 5000 | 0.506 |
| 12:24 ET | 5000 | 0.528001 |
| 12:26 ET | 5000 | 0.506 |
| 12:35 ET | 500 | 0.53 |
| 12:37 ET | 175 | 0.5299 |
| 01:47 ET | 200 | 0.53 |
| 02:20 ET | 100 | 0.506 |
| 02:59 ET | 800 | 0.55 |
| 03:06 ET | 2500 | 0.55 |
| 03:33 ET | 100 | 0.505 |
| 03:57 ET | 1500 | 0.524701 |
| 04:00 ET | 200 | 0.55 |
Nov 28, 2023
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Trinity Biotech PLC | 21.0M | -0.4x | --- |
Minerva Surgical Inc | 18.7M | -0.3x | --- |
Sientra Inc | 8.3M | -0.1x | --- |
Retractable Technologies Inc | 33.5M | -3.0x | --- |
Orgenesis Inc | 14.7M | -0.5x | --- |
Dalrada Financial Corp | 22.5M | -1.0x | --- |
Company Information
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot, EZ and EZ. It supplies this market with other products through its clinical chemistry business. It manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.
Contact Information
- Headquarters
- Ida Business Park Bray, Co Wicklow, IrelandBRAY, Ireland 18
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Aris Kekedjian
- Founder, Executive Director
- Ronan O'caoimh
- Chief Financial Officer, Executive Director, Company Secretary
- John Gillard
- Chief Technology Officer
- Gary Keating
- Chief Accounting Officer
- Simon Dunne
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.0M |
|---|---|
Revenue (TTM) | $66.3M |
Shares Outstanding | 38.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $-1.37 |
Book Value | $-0.05 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -50.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
